Reshma Tendulkar

Dr. Reshma Tendulkar

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in Proteomes
Verified
Journal Article
Open access
PDF file
MJMukul Jain
Mukul Jain
RDRupal Sanjay Dhariwal
Rupal Sanjay Dhariwal
NPNIL SANJAY PATIL
NIL SANJAY PATIL
SOSandhya Ojha
Sandhya Ojha
RTReshma Tendulkar
Reshma Tendulkar
Prashant KaushikPrashant Kaushik
Prashant Kaushik
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder characterized by progressive cognitive decline and memory loss. Early and accurate diagnosis of AD is crucial for implementing timely interventions and developing effective therapeutic strategies. Proteome-based biomarkers have emerged as promising tools for AD diagnosis and prognosis due to their ability to reflect disease-specific molecular alterations. There is of great significance for biomarkers in AD diagnosis and management. It emphasizes the limitations of existing diagnostic approaches and the need for reliable and accessible biomarkers. Proteomics, a field that comprehensively analyzes the entire protein complement of cells, tissues, or bio fluids, is presented as a powerful tool for identifying AD biomarkers. There is a diverse range of proteomic approaches employed in AD research, including mass spectrometry, two-dimensional gel electrophoresis, and protein microarrays. The challenges associated with identifying reliable biomarkers, such as sample heterogeneity and the dynamic nature of the disease. There are well-known proteins implicated in AD pathogenesis, such as amyloid-beta peptides, tau protein, Apo lipoprotein E, and clusterin, as well as inflammatory markers and complement proteins. Validation and clinical utility of proteome-based biomarkers are addressing the challenges involved in validation studies and the diagnostic accuracy of these biomarkers. There is great potential in monitoring disease progression and response to treatment, thereby aiding in personalized medicine approaches for AD patients. There is a great role for bioinformatics and data analysis in proteomics for AD biomarker research and the importance of data preprocessing, statistical analysis, pathway analysis, and integration of multi-omics data for a comprehensive understanding of AD pathophysiology. In conclusion, proteome-based biomarkers hold great promise in the field of AD research. They provide valuable insights into disease mechanisms, aid in early diagnosis, and facilitate personalized treatment strategies. However, further research and validation studies are necessary to harness the full potential of proteome-based biomarkers in clinical practice.

20 December 2025 in Asian Journal of Psychiatry
Verified
Journal Article
Closed access
MTMugdha Tendulkar
Mugdha Tendulkar
RTReshma Tendulkar
Reshma Tendulkar

1 January 2024 in Current Molecular Medicine
Verified
Journal Article
Closed access
PDF file
RTReshma Tendulkar
Reshma Tendulkar
MTMugdha Tendulkar
Mugdha Tendulkar
Exosomes are vesicles secreted by the plasma membrane of the cells delimited by a lipid bilayer membrane into the extracellular space of the cell. Their release is associated with the disposal mechanism to remove unwanted materials from the cells. Exosomes released from primary tumour sites migrate to other parts of the body to create a metastatic environment for spreading the tumour cells. We have reviewed that exosomes interfere with the tumour progression by (i) promoting angiogenesis, (ii) initiating metastasis, (iii) regulating tumour microenvironment (TME) and inflammation, (iv) modifying energy metabolism, and (v) transferring mutations. We have found that EVs play an important role in inducing tumour drug resistance against anticancer drugs. This review discusses the potential of exosomes to generate a significant therapeutic effect along with improved diagnosis, prognosis, insights on the various research conducted and their significant findings of our interest.

1 January 2026 in Psychiatry Research: Neuroimaging
Verified
Journal Article
Closed access
MTMugdha Tendulkar
Mugdha Tendulkar
RTReshma Tendulkar
Reshma Tendulkar

23 February 2026
Verified
Book Chapter
Closed access
PDF file
MTMugdha Tendulkar
Mugdha Tendulkar
RTReshma Tendulkar
Reshma Tendulkar
GAgholamreza abdi
gholamreza abdi

17 January 2023 in AIDASCO Reviews
Verified
Journal Article
Open access
PDF file
RTReshma Tendulkar
Reshma Tendulkar
SPShefali Patil
Shefali Patil
NSNeha Sawant
Neha Sawant
BCBhairavee Chimane
Bhairavee Chimane
Endometriosis is the proliferation of various tissues that resemble the uterine lining; these tissues develop inside lower abdominal reproductive organs, such as the ovaries, fallopian tubes, tissues that support the uterus, and other uterine surface regions. The lungs, brain, and skin are examples of non-pelvic tissues where spreadability was seen. However, endometrial-problem may also result in Ovarian Cancer and breast cancer if proper treatment of endometriosis in women is ignored. In conventional pharmaceutical therapies, nonsteroidal anti-inflammatory drugs, as well as androgens, aromatase inhibitors, selective progesterone receptor modulators, oral contraceptives, and gonadotropin-releasing hormone agonists, are used.